iTonic Holdings (NASDAQ: ITOC) announced a $20 million private placement deal on Monday, sparking a sharp rally in after-hours trading—even as the stock remains deeply down over the past year.
Key Points
- iTonic is raising $20 million through a private share placement to strengthen its capital base.
- The company will issue 100 million shares at $0.20 each, with a six-month lock-up period.
- Shares jumped about 60% in after-hours trading following the announcement.
- Despite the rally, the stock is down over 92% in the past year.
- The fundraising comes amid a strategic shift toward AI-driven healthcare following its recent acquisition and rebrand.
Private Placement to Raise Fresh Capital
The company revealed it has entered into a private investment agreement to issue new shares, thereby signaling a push to strengthen its capital base amid an ongoing strategic transition.
Under the terms of the deal, iTonic will sell 100 million Class A ordinary shares at $0.20 per share, raising approximately $20 million in gross proceeds. The agreement was signed on Sunday and subsequently disclosed in a filing with the U.S. Securities and Exchange Commission (SEC).
The transaction is expected to close in April, subject to customary conditions. Notably, the newly issued shares will carry a six-month lock-up period, which may help limit immediate selling pressure and therefore support post-issuance price stability.
Market Reaction and Stock Performance
Investors reacted quickly to the announcement. Shares of iTonic Holdings (NASDAQ: ITOC) surged roughly 60% in after-hours trading, reaching $0.45.
Despite recent short-term gains, the company’s long-term trajectory remains weak. Its stock has dropped 92.71% over the past year, underscoring persistent challenges to its market valuation.
At present, the company holds a market capitalization of around $5 million. Moreover, it also recently hit a 52-week low of $0.25, underscoring the stock’s volatility.
Strategic Backdrop: Acquisition and Transformation
To better understand the current fundraising effort, it is important to consider recent corporate developments. In December, Pheton Holdings completed its acquisition of a 51% stake in iTonic Corporation, a U.S.-based home health AI company, with the transaction closing on November 25. As part of the deal, Pheton issued 4 million newly created Class A shares tied to performance-based milestones.
The agreement also included warrants for up to 3 million additional shares at an exercise price of $3.10, contingent on both quarterly and annual targets.
First announced in August 2025, the acquisition marked a strategic pivot, expanding the company’s focus beyond brachytherapy into broader healthcare technology and AI-driven solutions.
Rebranding and Future Direction
Following the acquisition, the company moved to align its identity with its evolving strategy.
In January, Pheton Holdings announced it would rebrand as iTonic Holdings Ltd., alongside a ticker change from PTHL to ITOC. Trading under the new symbol began on January 16, 2026, on the Nasdaq Capital Market.
The rebranding underscores the company’s shift toward advanced healthcare technologies, with a growing emphasis on artificial intelligence as a core driver of future growth.
Stay on top of healthcare stocks with our Healthcare Stock updates.
